Skip to main content

Table 3 Completion status, enrollment, and result reporting among completed registered trials, 2000–2020

From: Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020

Year started

Completed

Time to completion

Sample sizea

Sample size categories (%)

Reported results

Time to report resultsd

N

Years (median, IQR)

(Median, IQR)

01–50

50–100

101–500

500–1000

>1000

Yes

N (%)

<12 mos.

N (%)

Months

Median (IQR)

2000

1572

4.3 (2.3, 6.8)

82 (33, 256)

38.3

17.6

28.8

8.3

7

137 (8.7)

0 (0)

49 (20, 87)

2001

2038

3.9 (2.0, 6.3)

91 (37, 270)

34.6

19.6

30.6

7.8

7.4

207 (10.2)

0 (0)

55 (27, 97)

2002

3000

3.4 (1.5, 5.5)

82 (36, 257)

37.8

18.9

31.7

7.3

4.3

359 (12.0)

0 (0)

57 (22, 84)

2003

4062

3.3 (1.7, 5.1)

81 (36, 251)

34.6

20.2

31.8

7.7

5.6

650 (16.0)

0 (0)

53 (23, 79)

2004

5261

2.9 (1.5, 4.6)

75 (33, 242)

37.7

19.0

31.9

7.8

5.2

1000 (19.0)

0 (0)

47 (21, 72)

2005

6240

2.6 (1.4, 4.3)

69 (30, 200)

39.2

19.2

30.8

6.3

4.5

1526 (24.5)

0 (0)

39 (19, 69)

2006

7221

2.3 (1.3, 3.9)

62 (29, 200)

38.4

18.9

30.7

6.8

5.2

2296 (31.8)

0 (0)

32 (14, 61)

2007b

7888

2.0 (1.0, 3.7)

60 (25, 168)

40.3

20.6

28.5

5.9

4.7

2840 (36.0)

0 (0)

29 (13, 56)

2008

8926

1.9 (0.8, 3.5)

58 (24, 150)

42.2

20.1

29.0

5.0

3.7

3165 (35.5)

9 (0.1)

27 (12, 52)

2009

9605

1.9 (0.9, 3.4)

58 (24, 150)

42.6

20.7

28.1

4.8

3.8

3322 (34.6)

16 (0.2)

22 (12, 44)

2010

9860

1.9 (0.8, 3.4)

57 (24, 149)

43.7

20.2

27.7

4.9

3.6

3136 (31.8)

20 (0.2)

19 (12, 39)

2011

10,320

1.8 (0.8, 3.2)

60 (25, 150)

43.1

20.7

27.6

4.8

3.8

3135 (30.4)

27 (0.3)

18 (11, 35)

2012

10,683

1.9 (0.9, 3.3)

59 (24, 150)

43.6

21.1

27.1

4.4

3.7

3069 (28.7)

18 (0.2)

15 (11, 30)

2013

10,974

1.8 (0.8, 3.2)

56 (24, 140)

45.7

21.2

25.9

4.0

3.2

3192 (29.1)

51 (0.5)

14 (11, 27)

2014

11,744

1.7 (0.8, 3.0)

57 (24, 140)

46.0

21.1

25.7

3.7

3.5

3107 (26.5)

51 (0.4)

13 (11, 24)

2015c

11,917

1.6 (0.8, 2.8)

60 (25, 140)

45.2

21.9

25.8

3.9

3.3

3034 (25.5)

57 (0.5)

12 (11, 22)

2016

11,720

1.5 (0.8, 2.7)

59 (24, 138)

46.4

22.0

24.5

3.6

3.5

2635 (22.5)

41 (0.3)

12 (11, 20)

2017

11,144

1.3 (0.7, 2.3)

60 (26, 138)

47.0

23.1

23.7

3.0

3.3

2268 (20.4)

14 (0.1)

12 (11, 18)

2018

10,118

1.1 (0.5, 1.9)

60 (26, 138)

49.7

22.8

22.0

2.9

2.6

1643 (16.2)

30 (0.3)

12 (10, 16)

2019

7925

0.8 (0.4, 1.5)

60 (28, 130)

52.7

24.0

19.0

2.1

2.2

862 (10.9)

53 (0.7)

11 (9, 13)

2020

5282

0.6 (0.3, 1.0)

62 (30, 150)

49.6

23.5

21.1

2.5

3.3

358 (6.8)

75 (1.4)

10 (6, 12)

  1. aActual sample size; byear ClinicalTrials.gov result database launched; cresults required to be reported within 12 months of trial’s primary completion date for applicable clinical trials; dnot all results required to post results, only trials that meet definition of an applicable clinical trial